Ataraxis AI

About Ataraxis AI

Ataraxis AI is focused on transforming cancer care through AI precision medicine. Their mission is to address previously unsolvable problems in cancer prognosis and treatment selection by leveraging cutting-edge AI foundation models and multi-modal data to empower physicians with advanced tools for improved treatment selection and patient outcomes.

Products & Services

Ataraxis Breast:An AI-native prognostic/predictive test for breast cancer, clinically validated with data from 8,161 patients across 15 institutions. It identifies low- and high-risk patients more accurately than standard genomic assays and offers same-day results without exhausting physical tissue.

Kestrel:A pan-cancer AI foundation model trained on hundreds of millions of pathology slide images to extract novel tumor morphology information, correlating strongly with patient outcomes and treatment response.

Specialties

AI Precision Medicine Cancer Prognosis and Treatment Selection Multi-modal Data Analysis Pan-cancer Foundation Models Breast Cancer Diagnostics

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series A T: - FT: Series A	A: 20400000 MR: - FA: 20.4 million FAN: 20400000	D: 2025-03-05 FD: 2025-03-05	10 investors

Series A Latest

2025-03-05

$20.4M

10 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

J

Jan Witowski

Chief Executive Officer & Co-Founder

LinkedIn (Pro only)

K

Krzysztof Geras

Chief Scientist & Co-Founder

Y

Yann LeCun

Chief AI Scientist at Meta

LinkedIn (Pro only)

L

Lajos Pusztai

Professor of Medicine and Co-Director of the Yale Breast Center at Yale School of Medicine

F

Francisco J. Esteva

Chief of Breast Medical Oncology

F

Freya Schnabel

Director of Breast Surgery

View 6 more team members with Pro

Unlock Full Team Directory

Recent News

Ataraxis AI Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised